Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EHC
EHC logo

EHC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
98.520
Open
97.690
VWAP
96.70
Vol
403.97K
Mkt Cap
9.70B
Low
94.990
Amount
39.06M
EV/EBITDA(TTM)
9.35
Total Shares
99.42M
EV
12.91B
EV/OCF(TTM)
10.97
P/S(TTM)
1.68
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
Show More

Events Timeline

(ET)
2026-03-18
16:50:00
Encompass Health to Build 40-Bed Rehabilitation Hospital in Delaware
select
2026-02-13 (ET)
2026-02-13
08:10:00
Encompass Health to Build 50-Bed Rehab Hospital in Mississippi
select
2026-02-12 (ET)
2026-02-12
09:30:00
Enhabit and Encompass Health Awarded $43.1M
select
2026-02-05 (ET)
2026-02-05
20:00:00
Amazon Falls Over 10% After Earnings Report
select
2026-02-05
16:40:00
Sees FY26 Revenue at $6.365B-$6.465B
select
2026-02-05
16:30:00
Company Reports Q4 Revenue of $1.54B
select
2025-12-02 (ET)
2025-12-02
21:30:00
Bitcoin Rebounds Supporting Market Stabilization; Multiple Companies Release Earnings
select
2025-12-02
12:11:00
Banco Santander Sells 3.5% Stake in Santander Bank Polska for $473.1M
select
link
2025-12-01 (ET)
2025-12-01
16:40:00
Encompass Health Affirms FY25 Revenue Guidance of $5.905B-$5.955B
select

News

PRnewswire
8.5
03-18PRnewswire
Encompass Health Announces New Rehabilitation Hospital in Delaware
  • New Hospital Announcement: Encompass Health has announced plans to build a 40-bed freestanding rehabilitation hospital in Bear, Delaware, aimed at providing high-quality rehabilitation care for patients recovering from strokes and neurological disorders, significantly enhancing access for local residents.
  • Comprehensive Treatment Services: The new facility will offer 24-hour nursing care, physical, occupational, and speech therapies designed to help patients restore function and improve their quality of life, reflecting the company's commitment to addressing patient needs in rehabilitation.
  • Facility Features: The hospital will include private patient rooms, a therapy gym equipped with advanced rehabilitation technologies, an activities of daily living suite, and an in-house dialysis suite, aiming to provide a holistic rehabilitation experience that enhances patient independence and quality of life.
  • Market Expansion Strategy: This new hospital marks Encompass Health's second location in Delaware, further solidifying its national network of 174 rehabilitation hospitals across 39 states and Puerto Rico, demonstrating the company's ongoing commitment to growth and investment in the rehabilitation healthcare market.
Newsfilter
8.5
03-18Newsfilter
Encompass Health Announces New Rehabilitation Hospital in Delaware
  • New Hospital Construction: Encompass Health has announced plans to build a 40-bed freestanding rehabilitation hospital in Bear, Delaware, aimed at providing high-quality rehabilitation services for patients recovering from strokes, neurological disorders, and spinal cord injuries, which is expected to significantly enhance recovery opportunities for local patients.
  • Comprehensive Treatment Services: The new hospital will offer 24-hour nursing care along with physical, occupational, and speech therapies designed to help patients restore function and improve their quality of life, reflecting the company's commitment to addressing patient needs in the rehabilitation sector.
  • Facility Features: The hospital will include private patient rooms, a therapy gym equipped with advanced rehabilitation technologies, an activities of daily living suite, and an in-house dialysis suite, aiming to provide a holistic rehabilitation experience that enhances patient independence and quality of life.
  • Regional Impact: This expansion will establish Encompass Health's second location in Delaware, further solidifying its leadership position in the U.S. rehabilitation hospital sector and providing greater access to rehabilitation services for residents of New Castle County and surrounding areas.
Globenewswire
7.0
03-17Globenewswire
Pomerantz LLP Investigates Encompass Health for Securities Fraud
  • Securities Fraud Investigation: Pomerantz LLP is investigating whether Encompass Health and its executives have engaged in securities fraud or other unlawful business practices, which could undermine investor confidence and lead to stock price volatility.
  • Safety Issues Exposed: On July 15, 2025, The New York Times reported that for-profit hospitals operated by Encompass perform below average on key safety measures, particularly highlighting 34 facilities with significantly worse rates of preventable readmissions, potentially attracting regulatory scrutiny.
  • Significant Stock Drop: Following the publication of the article, Encompass's stock price fell by $12.39, a decline of 10.35%, closing at $107.28, reflecting market concerns regarding the company's governance and operational safety.
  • Potential Legal Action: Due to the securities fraud allegations, investors are advised to contact Pomerantz LLP, which may lead to the initiation of a class action lawsuit, thereby impacting the company's reputation and future financial performance.
Globenewswire
7.0
03-16Globenewswire
Encompass Health Under Investigation for Potential Violations
  • Safety Performance Issues: According to a New York Times report, Encompass Health's for-profit hospitals are performing below average on key safety measures, with 34 facilities rated by Medicare as having statistically significantly higher rates of preventable readmissions, raising concerns about patient safety and the company's reputation.
  • Fatal Errors Raise Alarm: The report highlighted several alarming mistakes leading to patient fatalities in Encompass-owned facilities, which not only raises public concerns about the quality of care but also exposes the company to potential legal liabilities and compensation claims, further impacting its financial health.
  • Legal Investigation Initiated: Lowey Dannenberg P.C. is investigating whether Encompass Health has violated federal securities laws, and if confirmed, the company could face substantial fines and lawsuits, adversely affecting shareholder interests.
  • Investor Loss Risk: Should investors suffer losses due to Encompass's potential violations, it may trigger class-action lawsuits, increasing uncertainty in the market and potentially impacting the company's stock performance.
PRnewswire
7.0
03-12PRnewswire
Pomerantz LLP Investigates Encompass Health Securities Fraud Claims
  • Securities Fraud Investigation: Pomerantz LLP is investigating on behalf of investors of Encompass Health Corporation whether there have been securities fraud or other unlawful business practices, indicating serious concerns regarding corporate governance.
  • Safety Issues Exposed: An article by The New York Times reported that for-profit hospitals operated by Encompass perform below average on key safety measures, particularly highlighting 34 facilities with statistically significantly worse rates of preventable readmissions, which may lead to decreased investor confidence.
  • Significant Stock Drop: Following the publication of the report, Encompass's stock price fell by $12.39, or 10.35%, closing at $107.28 per share on July 15, 2025, reflecting market concerns over the quality of the company's operations.
  • Potential Legal Consequences: Pomerantz LLP, recognized as a leading securities litigation firm, may initiate a class action lawsuit against Encompass if the investigation confirms wrongdoing, which could have significant implications for the company's future financial health and reputation.
Barron's
4.5
03-11Barron's
U.S. Markets Closed Wednesday with Mixed Results as Nebius Group Outperformed and Fair Isaac Underperformed
  • Stock Market Performance: U.S. stock indexes ended Wednesday with mixed results, with one index increasing by 0.08%.

  • Index Movements: Another index also rose by 0.08%, while a third index experienced a decline of 0.61%.

Wall Street analysts forecast EHC stock price to rise
5 Analyst Rating
Wall Street analysts forecast EHC stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
134.00
Averages
146.75
High
160.00
Current: 0.000
sliders
Low
134.00
Averages
146.75
High
160.00
Barclays
NULL -> Overweight
maintain
$150 -> $153
AI Analysis
2026-02-06
Reason
Barclays
Price Target
$150 -> $153
AI Analysis
2026-02-06
maintain
NULL -> Overweight
Reason
Barclays raised the firm's price target on Encompass Health to $153 from $150 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q4 report.
Barclays
Andrew Mok
Overweight
maintain
$141 -> $150
2025-10-30
Reason
Barclays
Andrew Mok
Price Target
$141 -> $150
2025-10-30
maintain
Overweight
Reason
Barclays analyst Andrew Mok raised the firm's price target on Encompass Health to $150 from $141 and keeps an Overweight rating on the shares. The company reported a modest Q4 beat, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EHC
Unlock Now

Valuation Metrics

The current forward P/E ratio for Encompass Health Corp (EHC.N) is 18.83, compared to its 5-year average forward P/E of 19.42. For a more detailed relative valuation and DCF analysis to assess Encompass Health Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
19.42
Current PE
18.83
Overvalued PE
21.49
Undervalued PE
17.35

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
11.03
Current EV/EBITDA
10.69
Overvalued EV/EBITDA
11.87
Undervalued EV/EBITDA
10.19

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.49
Current PS
1.70
Overvalued PS
1.74
Undervalued PS
1.24

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what other stocks should I buy and why
Intellectia · 14 candidates
Market Cap: >= 10.00BAnalyst Consensus: Strong Buy, Moderate BuyEps 5yr Cagr: >= 10Pe Ttm: 10 - 35Target Price Upside Potential: MoreAbovePriceOne Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
PTC logo
PTC
PTC Inc
19.39B
MSFT logo
MSFT
Microsoft Corp
3.01T
NVO logo
NVO
Novo Nordisk A/S
171.90B
SEIC logo
SEIC
SEI Investments Co
10.00B
BMRN logo
BMRN
BioMarin Pharmaceutical Inc
11.62B
BR logo
BR
Broadridge Financial Solutions Inc
22.04B
what are the best stocks to buy today
Intellectia · 16 candidates
Market Cap: >= 10.00BRegion: USAnalyst Consensus: Strong Buy, Moderate BuyList Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePriceMoving Average Relationship: PriceAboveMA20
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.65T
PDD logo
PDD
PDD Holdings Inc
150.14B
QCOM logo
QCOM
Qualcomm Inc
149.82B
SMFG logo
SMFG
Sumitomo Mitsui Financial Group, Inc
148.10B
SNY logo
SNY
Sanofi SA
114.04B
CEG logo
CEG
Constellation Energy Corp
106.46B
what stock to buy Monday
Intellectia · 5 candidates
Market Cap: >= 10.00BBeta: LowRisk, ModerateRiskWeekly Average Turnover: >= 1,000,000Rsi 14: <= 35Week Price Change Pct: >= $-1.00
Ticker
Name
Market Cap$
top bottom
ET logo
ET
Energy Transfer LP
60.60B
MPLX logo
MPLX
MPLX LP
56.57B
PAA logo
PAA
Plains All American Pipeline LP
13.48B
YMM logo
YMM
Full Truck Alliance Co Ltd
10.30B
EHC logo
EHC
Encompass Health Corp
10.00B
find similar stocks of hims and hers
Intellectia · 208 candidates
Market Cap: 300.00M - 15.00BPs Ratio: <= 15.00Is Optionable: TrueAnnual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
GH logo
GH
Guardant Health Inc
14.98B
ICLR logo
ICLR
ICON PLC
14.12B
PEN logo
PEN
Penumbra Inc
14.03B
SOLV logo
SOLV
Solventum Corp
13.94B
SNN logo
SNN
Smith & Nephew PLC
13.91B
NBIX logo
NBIX
Neurocrine Biosciences Inc
13.50B
share the top 100 instead of 12
Intellectia · 24 candidates
Market Cap: >= 1000.00MNet Margin: >= 10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: 17 - 23Return On Equity: >= 18.0%Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
NVS logo
NVS
Novartis AG
278.44B
COIN logo
COIN
Coinbase Global Inc
61.19B
AU logo
AU
Anglogold Ashanti PLC
51.18B
KGC logo
KGC
Kinross Gold Corp
43.05B
FUTU logo
FUTU
Futu Holdings Ltd
23.11B
FTI logo
FTI
TechnipFMC PLC
21.93B

Whales Holding EHC

L
Leeward Investments, LLC
Holding
EHC
+16.19%
3M Return
O
Oberweis Asset Management, Inc.
Holding
EHC
+13.19%
3M Return
F
Fuller & Thaler Asset Management, Inc.
Holding
EHC
+11.29%
3M Return
S
Systematic Financial Management LP
Holding
EHC
+9.20%
3M Return
C
Copeland Capital Management, LLC
Holding
EHC
+4.62%
3M Return
R
Reinhart Partners, LLC
Holding
EHC
+4.17%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Encompass Health Corp (EHC) stock price today?

The current price of EHC is 96.5925 USD — it has decreased -0.95

What is Encompass Health Corp (EHC)'s business?

Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.

What is the price predicton of EHC Stock?

Wall Street analysts forecast EHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EHC is146.75 USD with a low forecast of 134.00 USD and a high forecast of 160.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Encompass Health Corp (EHC)'s revenue for the last quarter?

Encompass Health Corp revenue for the last quarter amounts to 1.54B USD, increased 9.94

What is Encompass Health Corp (EHC)'s earnings per share (EPS) for the last quarter?

Encompass Health Corp. EPS for the last quarter amounts to 1.43 USD, increased 21.19

How many employees does Encompass Health Corp (EHC). have?

Encompass Health Corp (EHC) has 24611 emplpoyees as of March 31 2026.

What is Encompass Health Corp (EHC) market cap?

Today EHC has the market capitalization of 9.70B USD.